Pefloxacin induced changes in serotonergic innervation and mast cell number in rat salivary glands

References

• Abdollahi, M., Minaiee, B., and Yaaghoubi, A.A., 2003. Structural and functional changes by Ciprofloxacin of rat submandibular gland. Human and Experimental Toxicology, 22 (4), 177–181.
   PubMed Web of Science ®Google Scholar
• Amano, O., et al., 2012. Anatomy and histology of rodent and human major salivary glands: -overview of the Japan salivary gland society-sponsored workshop. Acta Histochemica Et Cytochemica, 45 (5), 241–250.
   PubMed Web of Science ®Google Scholar
• Badal, S., Her, Y.F., and Maher, L.J.R., 2015. Nonantibiotic effects of fluoroquinolones in mammalian Cells. The Journal of Biological Chemistry, 290 (36), 22287–22297.
   PubMed Web of Science ®Google Scholar
• Batbayar, B., et al., 2004. Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjögren's syndrome. Archives of Oral Biology, 49 (7), 529–538.
   PubMed Web of Science ®Google Scholar
• Chen, L., et al., 2014. Effect of diclofenac on the pharmacokinetics of moxifloxacin in rats. Drug Research, 64 (7), 343–347.
   Google Scholar
• Chernick, W., Bobyock, E., and Bradford, P., 1989. 5-Hydroxytryptamine modulation of rat parotid salivary gland secretion. Journal of Dental Research , 68 (1), 59–63.
   PubMed Web of Science ®Google Scholar
• Dalhoff, A., 2012. Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdisciplinary Perspectives on Infectious Diseases, 2012, 976273
   PubMedGoogle Scholar
• Etminan, M., Brophy, J.M., and Samii, A., 2014. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study. Neurology, 83 (14), 1261–1263.
   PubMed Web of Science ®Google Scholar
• Etminan, M., et al., 2012. Oral fluoroquinolones and the risk of retinal detachment. JAMA, 307 (13), 1414–1419.
   PubMed Web of Science ®Google Scholar
• Ferreira, J.N. and Hoffman, M.P., 2013. Interactions between developing nerves and salivary glands. Organogenesis, 9 (3), 199–205.
   PubMed Web of Science ®Google Scholar
• Frossi, B., et al., 2018. Is it time for a new classification of mast cells? What do we know about mast cell heterogeneity?. Immunological Reviews, 282 (1), 35–46.
   PubMed Web of Science ®Google Scholar
• Greene, E. C., 1959. Anatomy of the rat. New York(NY): Hafner.
   Google Scholar
• Gupta, K. and Harvima, I.T., 2018. Mast cell-neural interactions contribute to pain and itch. Immunological Reviews , 282 (1), 168–187.
   PubMed Web of Science ®Google Scholar
• Harvima, I.T., Nilsson, G., and Naukkarinen, A., 2010. Role of mast cells and sensory nerves in skin inflammation. Giornale Italiano Di Dermatologia e Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia e Sifilografia, 145 (2), 195–204.
   PubMed Web of Science ®Google Scholar
• Huang, W., et al., 2004. Localization and in situ quantification of 5-hydroxytryptamine and its receptor in rat submaxillary gland. Journal of Molecular Histology, 35 (1), 47–53.
   PubMed Web of Science ®Google Scholar
• Ilgin, S., et al., 2015. Ciprofloxacin-induced neurotoxicity: evaluation of possible underlying mechanisms. Toxicology Mechanisms and Methods, 25 (5), 374–381.
   PubMed Web of Science ®Google Scholar
• Inoue, H., et al., 2006. Gender difference in unstimulated whole saliva flow rate and salivary gland sizes. Archives of Oral Biology, 51 (12), 1055–1060.
   PubMed Web of Science ®Google Scholar
• Jiang, Y., Li, H., E.L., et al., 2013. Determination of pazufloxacin concentration in saliva, gingival crevicular fluid and serum of healthy adults using high-performance liquid chromatography. Journal of South Medical University, 33, 53–56.
   Google Scholar
• Johnsson, M., et al., 2016. In vivo studies of effects of antidepressants on parotid salivary secretion in the rat. Archives of Oral Biology, 67, 54–60.
   PubMed Web of Science ®Google Scholar
• Kelentey, B.A., et al., 1995. [Excretion of fluoroquinolones into saliva.]. Fogorvosi Szemle, 88, 293–297.
   PubMedGoogle Scholar
• Kelentey, B., et al., 1996. Inhibition of rat parotid gland growth response induced by chronic isoproterenol following treatment with quinolone antibiotics. Molecular and Cellular Biochemistry, 165 (1), 55–63.
   PubMed Web of Science ®Google Scholar
• Kelentey, B., et al., 2010. Modification of innervation pattern by fluoroquinolone treatment in the rat salivary glands. Anatomical Record (Hoboken, N.J.: 2007), 293 (2), 271–279.
   PubMedGoogle Scholar
• Kempuraj, D., et al., 2017. Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis. Frontiers in Neuroscience, 11, 703.
   PubMed Web of Science ®Google Scholar
• Kerr, M., et al., 1996. Effect of a quinolone antibiotic on the rat parotid gland. Journal of Dental Research, 75 (IADR abstracts), 2858.
   Google Scholar
• Kispelyi, B., et al., 2014. Neuropeptide analysis of oral mucosa in diabetic rats. Neuroimmunomodulation, 21 (4), 213–220.
   PubMed Web of Science ®Google Scholar
• Konttinen, Y., et al., 2000. Mast cell derangement in salivary glands in patients with Sjögren's syndrome. Rheumatology International, 19 (4), 141–147.
   PubMed Web of Science ®Google Scholar
• Kritas, S.K., et al., 2014. Nerve growth factor interactions with mast cells. International Journal of Immunopathology and Pharmacology , 27 (1), 15–19.
   PubMed Web of Science ®Google Scholar
• Li, Q., et al., 2002. Comparative study on salivary distribution of fluoroquinolones in rats. Biological & Pharmaceutical Bulletin, 25 (8), 1084–1089.
   PubMed Web of Science ®Google Scholar
• Louhimies, S., 2002. Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes. ATLA, 30, 217–219.
   Google Scholar
• Maurer, M. and Pucillo, C., 2018. What we know (and don't know) about the biology and functions of mast cells and basophils. Immunological Reviews, 282 (1), 5–7.
   PubMed Web of Science ®Google Scholar
• Metcalfe, D.D., Baram, D., and Mekori, Y.A., 1997. Mast cells. Physiological Reviews , 77 (4), 1033–1079.
   PubMed Web of Science ®Google Scholar
• Morgado, C., et al., 2011. Changes in serotoninergic and noradrenergic descending pain pathways during painful diabetic neuropathy: the preventive action of IGF1. Neurobiology of Disease, 43 (1), 275–284.
   PubMed Web of Science ®Google Scholar
• Mukai, K., et al., 2018. Mast cells as sources of cytokines, chemokines, and growth factors. Immunological Reviews, 282 (1), 121–150.
   PubMed Web of Science ®Google Scholar
• Muller, Y., et al., 2015. [Allergies and adverse events associated with fluoroquinolones]. Revue Medicale Suisse, 11 (469), 826–830.
   PubMedGoogle Scholar
• Olcay, E., et al., 2011. Oral toxicity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin: comparison of biomechanical and histopathological effects on Achilles tendon in rats. The Journal of Toxicological Sciences, 36 (3), 339–345.
   PubMed Web of Science ®Google Scholar
• Pubchem, C., 2005. Pefloxacin. [online]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/51081 [Accessed 20 January 2018].
   Google Scholar
• Rotimi, S.O., et al., 2015. Amoxillin- and pefloxacin-induced cholesterogenesis and phospholipidosis in rat tissues. Lipids in Health and Disease, 14, 13.
   PubMed Web of Science ®Google Scholar
• Serisier, D.J., 2012. Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacin. Drugs of today (Barcelona, Spain : 1998), 48 (5), 339–351.
   PubMed Web of Science ®Google Scholar
• Shrivastava, R., et al., 2015. An in vitro comparison of endodontic medicaments propolis and calcium hydroxide alone and in combination with ciprofloxacin and moxifloxacin against Enterococcus faecalis. The Journal of Contemporary Dental Practice, 16, 394–399.
   PubMedGoogle Scholar
• Singh, J., et al., 2018. Under ambient UVA exposure, pefloxacin exhibits both immunomodulatory and genotoxic effects via multiple mechanisms. Journal of Photochemistry and Photobiology. B, 178, 593–605.
   PubMed Web of Science ®Google Scholar
• Sommer, C., 2010. Serotonin in pain and pain control. In: Christian, P, Barry J. ed. Handbook of the Behavioural Neurobiology of Serotonin. Burlington, London: Elsevier B.V., 457–471.
   Google Scholar
• Tomé, A. and Filipe, A., 2011. Quinolones: review of psychiatric and neurological adverse reactions. Drug Safety, 34 (6), 465–488.
   PubMed Web of Science ®Google Scholar
• Tsai, W.C. and Yang, Y.M., 2011. Fluoroquinolone-associated tendinopathy. Chang Gung Medical Journal, 34 (5), 461–467.
   PubMedGoogle Scholar
• Turner, J.T., et al., 1996. A regulatory role in mammalian salivary glands for 5-hydroxytryptamine receptors coupled to increased cyclic AMP production. Journal of Dental Research, 75 (3), 935–941.
   PubMed Web of Science ®Google Scholar
• Van Winkelhoff, A., et al., 2016. Susceptibility of periodontal pathogens to moxifloxacin: an in vitro study. International Journal of Antimicrobial Agents, 48 (5), 570–572.
   PubMed Web of Science ®Google Scholar
• Xiang, Z., and Nilsson, G., 2000. IgE receptor-mediated release of nerve growth factor by mast cells. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology, 30 (10), 1379–1386.
   PubMed Web of Science ®Google Scholar